MedTrace Logo

A Comparison of microRNA Samples in Patients With Nasal Polyps and Aspirin Exacerbated Respiratory Disease and Those With Nasal Polyps Only

NCT01631773 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2014-10-07

No results posted yet for this study

Summary

We hypothesize that the miRNA expression in subjects with nasal polyps and Aspirin-exacerbated respiratory disease (AERD) differs from the miRNA expressed in subjects with nasal polyps but without Aspirin-exacerbated respiratory disease (AERD).

Conditions

  • Aspirin-exacerbated Respiratory Disease
  • Nasal Polyp

Interventions

GENETIC

microRNA

Biological samples will be taken from subjects w/ Nasal polyps \& AERD disease and subjects w/ nasal polyps without AERD. MicroRNA will be analyzed to compare genetic similarities and differences between the two study groups.

Sponsors & Collaborators

  • University of South Florida

    lead OTHER

Principal Investigators

  • Dennis Ledford, MD · Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida College of Medicine

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01631773 on ClinicalTrials.gov